Pampanga rolls out Sinovac vaccines for frontliners | Inquirer News

Pampanga rolls out Sinovac vaccines for frontliners

/ 06:08 PM March 08, 2021

CITY OF SAN FERNANDO –– The province of Pampanga on Monday rolled out the first doses of the Chinese CoronaVac vaccine, prioritizing the healthcare frontliners.

Dr. Monserrat Chichioco, medical director of the Jose B. Lingad Memorial General Hospital (JBLMGH) in this capital city, received the first jab of CoronaVac in the facility.

The vaccine is manufactured by Sinovac Biotech Ltd. in China and was donated to the country.

Article continues after this advertisement

Over 400 medical frontliners at the JBLMGH signed up to receive the CoronaVax. At least 200 more would be vaccinated in other key COVID-19 referral hospitals in the province.

FEATURED STORIES

About 11,000 doses of the Sinovac vaccines were allotted to various hospitals in Central Luzon. INQ

LZB

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Chinese, Coronavirus, COVID-19, Pampanga, Regions

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.